Silver Book Fact

Every $1 spent on technological innovations in heart attack care has produced an estimated $7 gain.

Cutler D, McClellan M. Is Technological Change in Medicine Worth It?. Health Affairs. 2001; 20(5): 11-29. http://content.healthaffairs.org/content/20/5/11.full

Reference

Title
Is Technological Change in Medicine Worth It?
Publication
Health Affairs
Publication Date
2001
Authors
Cutler D, McClellan M
Volume & Issue
Volume 20, Issue 5
Pages
11-29
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Stroke rates among Afib patients
    In one year, 58,283 of the 1.265 million Medicare beneficiaries with atrial fibrillation that did not receive prophylaxis suffered a stroke. For those who did receive anti-coagulants, 38,468 suffered strokes.  
  • Use of antihypertensive therapies avoided an estimated $10.7 billion in 2002 direct medical costs as a result of fewer strokes. They also avoided an estimated $5.8 billion in 2002…  
  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.  
  • The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.
     
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.